Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Section: Veterinary Medicine

Equine Anesthesia: Protocols, Monitoring, and Complications

Equine anesthesia requires systematic planning, drug selection based on individual patient assessment, and continuous monitoring to manage the physiological challenges specific to horses. This article covers pre-anesthetic evaluation, sedation and premedication, induction protocols, maintenance options including total intravenous anesthesia (TIVA), monitoring of cardiovascular and respiratory function, anesthetic depth assessment, fluid therapy, common complications, recovery management, and professional escalation criteria. Content is drawn from peer-reviewed sources and official veterinary references to support clinical decision-making in equine practice.

At a Glance

Anesthetic Phase Key Actions Common Drug Options Primary Risks
Pre-anesthetic evaluation Physical exam, blood work, airway assessment, fasting Sedation with alpha-2 agonists (xylazine, detomidine, romifidine) Undetected comorbidities, aspiration pneumonia
Induction Rapid smooth transition to recumbency Ketamine + benzodiazepine or guaifenesin after alpha-2 sedation Excitement phase, trauma during induction
Maintenance Depth control, cardiovascular support Isoflurane, sevoflurane, or TIVA (romifidine-ketamine-midazolam) Hypotension, hypoxemia, respiratory depression
Recovery Safe return to standing Minimal stimulation, assisted recovery if needed Myopathy, neuropathy, fractures, cardiac arrest

Pre-Anesthetic Evaluation

A thorough pre-anesthetic evaluation reduces the risk of complications during equine anesthesia. The evaluation should include a complete physical examination, assessment of the horse's temperament and handling requirements, and review of the intended procedure and its duration.

Physical Examination and History

Begin with a systematic physical examination focusing on the cardiovascular and respiratory systems. Auscultate the heart for murmurs, arrhythmias, or abnormal rhythms. Assess respiratory rate and effort, and auscultate the lungs for abnormal sounds. Evaluate mucous membrane color and capillary refill time as indicators of perfusion. Palpate peripheral pulses, particularly the facial artery or digital arteries, to assess pulse quality and rhythm.

Record the horse's age, breed, weight, and body condition score. Obtain a history of previous anesthetic events, known drug reactions, and current medications. Note any history of colic, respiratory disease, or exercise intolerance. The Merck Veterinary Manual provides general guidance on pre-anesthetic assessment for horses, emphasizing the importance of identifying underlying disease before anesthesia (Merck Veterinary Manual, www.merckvetmanual.com).

Laboratory Evaluation

Pre-anesthetic blood work should include a complete blood count and serum biochemistry panel. Key parameters include packed cell volume, total protein, creatinine, blood urea nitrogen, glucose, electrolytes, and liver enzymes. For horses undergoing prolonged procedures or those with suspected systemic disease, additional testing such as coagulation profile or arterial blood gas analysis may be indicated.

Airway Assessment

Evaluate the upper airway for patency and any obstructions. Horses are obligate nasal breathers, so nasal passages must be clear. Assess for conditions such as dorsal displacement of the soft palate, laryngeal hemiplegia, or pharyngeal collapse that could compromise ventilation during anesthesia. The Merck Veterinary Manual notes that horses with upper airway obstructions are at increased risk for hypoxemia during anesthesia (Merck Veterinary Manual, www.merckvetmanual.com).

Fasting and Hydration Status

Withhold feed for 6 to 12 hours before anesthesia to reduce the risk of regurgitation and aspiration. Water should be available until 2 to 4 hours before induction. For horses with colic or other conditions requiring emergency anesthesia, fasting may not be possible, and the risk of aspiration must be managed with endotracheal intubation and cuff inflation.

Assess hydration status through skin turgor, mucous membrane moisture, and packed cell volume. Dehydrated horses are more prone to hypotension during anesthesia and may require fluid therapy before induction.

Sedation and Premedication

Sedation is essential for safe handling and smooth induction in horses. Alpha-2 adrenergic agonists are the most commonly used sedatives in equine practice.

Alpha-2 Agonists

Xylazine, detomidine, and romifidine are the primary alpha-2 agonists used in horses. These drugs provide sedation, analgesia, and muscle relaxation. The choice of agent depends on the desired duration of effect and the horse's temperament.

Xylazine produces rapid sedation of relatively short duration, typically 15 to 30 minutes. Detomidine provides longer sedation, lasting 30 to 60 minutes or more, with more profound analgesia. Romifidine offers intermediate duration with less ataxia compared to other alpha-2 agonists.

A study on detomidine and xylazine in donkeys (Equus asinus) provides comparative data on the sedative and analgesic effects of these drugs at different doses, which can inform clinical decisions in equids (Detomidine and xylazine, at different doses, in donkeys (Equus asinus), Revista Brasileira De Medicina Veterinaria, 2020, doi.org/10.29374/2527-2179.bjvm100820).

Combination Protocols

Combining alpha-2 agonists with other drugs can enhance sedation and reduce required doses. Common combinations include:

  • Alpha-2 agonist plus butorphanol for added sedation and analgesia
  • Alpha-2 agonist plus acepromazine for additional tranquilization, though acepromazine can cause hypotension
  • Alpha-2 agonist plus benzodiazepine (diazepam or midazolam) for muscle relaxation

Epidural Analgesia

For procedures involving the hindlimbs, perineum, or tail, epidural administration of alpha-2 agonists combined with local anesthetics provides regional analgesia and reduces the need for systemic drugs. A study on the efficacy of caudal epidural injection of xylazine-lidocaine HCl and detomidine-lidocaine HCl in domestic horses (Equus ferus caballus) demonstrates the clinical utility of these combinations for standing sedation and analgesia (Efficacy of caudal epidural injection of Xylazine-Lidocaine HCl and detomidine-lidocaine HCl in domestic horses (Equus ferus caballus), BMC Veterinary Research, 2025, doi.org/10.1186/s12917-025-04840-7).

Induction of Anesthesia

Induction should be rapid and smooth to minimize excitement, trauma, and stress. The goal is to achieve a plane of anesthesia sufficient for endotracheal intubation and positioning.

Injectable Induction Agents

Ketamine is the most common induction agent in horses, typically administered after sedation with an alpha-2 agonist. Ketamine produces dissociative anesthesia with good muscle relaxation when combined with a benzodiazepine or guaifenesin.

Standard induction protocols include:

  • Alpha-2 agonist sedation, followed by ketamine plus diazepam or midazolam
  • Alpha-2 agonist sedation, followed by ketamine plus guaifenesin
  • Tiletamine-zolazepam combination after alpha-2 agonist sedation

Guaifenesin

Guaifenesin is a central muscle relaxant often used as an induction adjunct. It is administered as a 5% to 10% solution to effect. Guaifenesin provides muscle relaxation without significant cardiovascular depression, making it useful for induction and as a component of TIVA protocols.

Endotracheal Intubation

After induction, the horse should be positioned in lateral or sternal recumbency for intubation. Use a cuffed endotracheal tube of appropriate size (typically 20 to 30 mm internal diameter for adult horses). Visualize the larynx using a laryngoscope or direct digital palpation. Inflate the cuff to provide a seal and prevent aspiration.

Confirm correct tube placement by observing chest wall movement, auscultating breath sounds, and checking for condensation in the tube. Secure the tube to the horse's head to prevent dislodgement.

Maintenance of Anesthesia

Maintenance can be achieved with inhalant anesthetics, injectable drugs (TIVA), or a combination of both. The choice depends on the procedure, available equipment, and the horse's condition.

Inhalant Anesthesia

Isoflurane and sevoflurane are the most commonly used inhalant anesthetics in horses. Both provide rapid induction and recovery with minimal metabolism.

Isoflurane is delivered in oxygen for maintenance, with vaporizer settings adjusted based on anesthetic depth. Sevoflurane is delivered at higher vaporizer settings for maintenance. Both agents cause dose-dependent cardiovascular depression, including hypotension and decreased cardiac output.

The Merck Veterinary Manual provides general guidance on inhalant anesthetic use in horses, noting that isoflurane and sevoflurane are preferred over halothane due to better cardiovascular stability (Merck Veterinary Manual, www.merckvetmanual.com).

Total Intravenous Anesthesia (TIVA)

TIVA involves continuous infusion of injectable anesthetics to maintain anesthesia without inhalant agents. TIVA is particularly useful for procedures where inhalant anesthesia is contraindicated or unavailable, and for horses with compromised cardiovascular function.

Common TIVA protocols include:

  • Romifidine-ketamine-midazolam: Romifidine bolus followed by infusion, ketamine bolus followed by infusion, midazolam bolus followed by infusion
  • Xylazine-ketamine-guaifenesin: Xylazine bolus followed by infusion, ketamine bolus followed by infusion, guaifenesin bolus followed by infusion

A review of total intravenous anesthesia in horses discusses the pharmacology and clinical application of TIVA protocols, highlighting the advantages of cardiovascular stability and reduced environmental pollution (Total intravenous anesthesia in horses, The Veterinary Clinics of North America. Equine Practice, 2013, pubmed.ncbi.nlm.nih.gov/23498048).

Alfaxalone has been investigated as an alternative for TIVA in horses. A study on alfaxalone for total intravenous anaesthesia in horses examines its pharmacokinetics and clinical effects, suggesting it may be a useful component of TIVA protocols (Alfaxalone for total intravenous anaesthesia in horses, Veterinary Anaesthesia and Analgesia, 2019, pubmed.ncbi.nlm.nih.gov/30713053).

Comparison of TIVA and Inhalant Anesthesia

A study comparing respiratory function during TIVA (romifidine, ketamine, midazolam) and isoflurane anesthesia in spontaneously breathing ponies found differences in blood gas analysis and cardiorespiratory variables between the two techniques (Comparison of respiratory function during TIVA (romifidine, ketamine, midazolam) and isoflurane anaesthesia in spontaneously breathing ponies Part I: blood gas analysis and cardiorespiratory variables, Veterinary Anaesthesia and Analgesia, 2014, pubmed.ncbi.nlm.nih.gov/25099938). This research provides evidence that TIVA may offer advantages in maintaining respiratory function compared to isoflurane in some cases.

Monitoring During Anesthesia

Continuous monitoring of cardiovascular, respiratory, and anesthetic depth parameters is essential for patient safety. The monitoring plan should be tailored to the procedure, the horse's condition, and available equipment.

Cardiovascular Monitoring

Heart rate and rhythm should be monitored continuously using electrocardiography (ECG). Place electrodes in a base-apex configuration for a clear tracing. Monitor for arrhythmias, including bradycardia, tachycardia, and premature complexes.

Arterial blood pressure is a critical parameter in equine anesthesia. Direct arterial blood pressure monitoring via catheterization of the facial or transverse facial artery provides the most accurate measurements. Indirect methods, such as oscillometric or Doppler devices, can be used but may be less reliable in hypotensive horses.

Normal mean arterial pressure (MAP) in anesthetized horses is 60 to 80 mmHg. MAP below 60 mmHg indicates hypotension requiring intervention. Systolic pressure should be maintained above 80 to 90 mmHg.

Respiratory Monitoring

Respiratory rate and depth should be monitored continuously. Observe chest wall movement and auscultate breath sounds regularly. Capnography provides end-tidal carbon dioxide (ETCO2) measurements, which reflect ventilation and can help detect hypoventilation or hyperventilation.

Normal ETCO2 in anesthetized horses is 35 to 45 mmHg. Values above 50 to 55 mmHg indicate hypoventilation and may require assisted ventilation. Pulse oximetry provides peripheral oxygen saturation (SpO2) readings, with values above 95% considered adequate.

Arterial blood gas analysis is the gold standard for assessing oxygenation and ventilation. PaO2 should be maintained above 80 to 100 mmHg, and PaCO2 should be maintained between 35 and 45 mmHg. Hypoxemia (PaO2 below 60 mmHg) requires immediate intervention.

Anesthetic Depth Monitoring

Assess anesthetic depth using multiple parameters:

  • Eye position and palpebral reflex: As depth increases, the eye rotates ventromedially and the palpebral reflex diminishes
  • Jaw tone: Decreased jaw tone indicates adequate muscle relaxation
  • Response to surgical stimulation: Movement or increased heart rate in response to stimulation indicates light anesthesia
  • Nystagmus: Horizontal nystagmus indicates light anesthesia

The Merck Veterinary Manual provides guidance on assessing anesthetic depth in horses, emphasizing the importance of using multiple parameters to avoid under- or over-anesthesia (Merck Veterinary Manual, www.merckvetmanual.com).

Temperature Monitoring

Monitor body temperature throughout anesthesia. Horses are prone to hypothermia due to their large surface area and the effects of anesthetic drugs on thermoregulation. Use a rectal or esophageal temperature probe. Maintain body temperature with warm blankets, forced-air warming devices, and warmed intravenous fluids.

Fluid Therapy During Anesthesia

Intravenous fluid therapy supports cardiovascular function and helps maintain blood pressure during anesthesia. Place a large-bore intravenous catheter (14 to 16 gauge) in the jugular vein before induction.

Crystalloid Fluids

Lactated Ringer's solution or isotonic saline are commonly used. Administer at a maintenance rate during anesthesia. Adjust the rate based on blood pressure, hydration status, and estimated fluid losses.

Colloid Fluids

For horses with hypotension refractory to crystalloid fluids, colloid solutions such as hetastarch or hydroxyethyl starch may be used. Administer slowly over 15 to 30 minutes. Monitor for signs of volume overload, including increased central venous pressure and pulmonary edema.

Blood Products

For horses with significant blood loss or anemia, whole blood or packed red blood cells may be required. Cross-match blood before transfusion when possible.

Common Complications and Management

Equine anesthesia carries significant risks, and complications can arise rapidly. Early recognition and prompt intervention are critical.

Hypotension

Hypotension (MAP below 60 mmHg) is the most common cardiovascular complication during equine anesthesia. Causes include:

  • Excessive anesthetic depth
  • Hypovolemia
  • Vasodilation from alpha-2 agonists or inhalant anesthetics
  • Cardiac dysfunction

Management steps:

  1. Reduce anesthetic depth if possible
  2. Increase fluid administration rate
  3. Administer inotropic support
  4. Consider vasopressors

The Merck Veterinary Manual discusses the management of hypotension during equine anesthesia, emphasizing the importance of maintaining MAP above 60 mmHg to ensure adequate organ perfusion (Merck Veterinary Manual, www.merckvetmanual.com).

Hypoxemia

Hypoxemia (PaO2 below 60 mmHg or SpO2 below 90%) can result from hypoventilation, ventilation-perfusion mismatch, or pulmonary disease. Horses are particularly prone to hypoxemia due to their large lungs and the effects of recumbency on pulmonary function.

Management steps:

  1. Increase inspired oxygen concentration to 100%
  2. Provide assisted or controlled ventilation
  3. Reposition the horse to improve lung perfusion
  4. Consider positive end-expiratory pressure (PEEP) if available
  5. Administer bronchodilators if bronchospasm is suspected

Cardiac Arrest

Cardiac arrest is a life-threatening emergency requiring immediate intervention. Causes include:

  • Severe hypotension or hypoxemia
  • Vagal stimulation during intubation or surgery
  • Electrolyte imbalances
  • Drug reactions

Management steps:

  1. Discontinue anesthetic agents
  2. Begin cardiopulmonary resuscitation (CPR) with chest compressions at 80 to 100 compressions per minute
  3. Administer epinephrine intravenously or intratracheally
  4. Provide ventilation with 100% oxygen
  5. Defibrillate if ventricular fibrillation is present and equipment is available

The Merck Veterinary Manual provides guidance on CPR in horses, noting that successful resuscitation is rare but possible with prompt intervention (Merck Veterinary Manual, www.merckvetmanual.com).

Respiratory Depression

Respiratory depression can result from anesthetic drugs, particularly opioids and alpha-2 agonists. Hypoventilation leads to hypercapnia and respiratory acidosis.

Management steps:

  1. Reduce anesthetic depth if possible
  2. Provide assisted or controlled ventilation
  3. Administer reversal agents if appropriate
  4. Monitor arterial blood gases to guide ventilation

Recovery Complications

The recovery period is a high-risk phase of equine anesthesia. Complications include:

  • Myopathy and neuropathy from prolonged recumbency
  • Fractures from uncontrolled recovery
  • Aspiration pneumonia
  • Cardiac arrest

Management strategies:

  1. Provide a quiet, padded recovery stall
  2. Minimize stimulation during recovery
  3. Assist recovery with head and tail ropes if needed
  4. Administer sedation as needed to control excitement
  5. Monitor for signs of myopathy (stiffness, reluctance to stand, muscle swelling)

The Merck Veterinary Manual emphasizes the importance of careful recovery management to reduce the risk of complications (Merck Veterinary Manual, www.merckvetmanual.com).

Records and Measurements

Accurate record-keeping during equine anesthesia is essential for patient safety and quality assurance. Maintain a detailed anesthetic record that includes:

  • Pre-anesthetic evaluation findings
  • Drug doses and administration times
  • Vital signs at 5- to 15-minute intervals
  • Fluid therapy volumes
  • Any complications and interventions
  • Recovery time and quality

Use standardized forms or electronic records to ensure consistency. Review records regularly to identify trends and areas for improvement.

Common Failure Patterns

Recognizing common failure patterns in equine anesthesia can help prevent complications.

Inadequate Pre-Anesthetic Evaluation

Failure to identify underlying disease before anesthesia increases the risk of complications. Horses with undetected cardiac disease, respiratory disease, or electrolyte imbalances are at higher risk for hypotension, arrhythmias, and cardiac arrest.

Improper Drug Dosing

Overdosing anesthetic drugs can cause profound cardiovascular and respiratory depression. Underdosing can lead to light anesthesia, movement, and stress. Calculate doses based on accurate body weight and adjust for individual patient factors.

Inadequate Monitoring

Failure to monitor vital signs continuously can delay recognition of complications. Hypotension, hypoxemia, and arrhythmias can develop rapidly and require immediate intervention.

Poor Recovery Management

Inadequate recovery facilities or improper management can lead to fractures, myopathy, and other complications. Provide a padded recovery stall, minimize stimulation, and assist recovery as needed.

Welfare and Safety Context

Equine anesthesia carries inherent risks, and patient welfare must be a primary consideration. The World Organisation for Animal Health (WOAH) provides standards for animal health and welfare that apply to veterinary procedures, including anesthesia (Animal Health and Welfare, World Organisation for Animal Health, www.woah.org/en/what-we-do/animal-health-and-welfare).

Key welfare considerations include:

  • Minimizing stress and pain during anesthesia
  • Ensuring adequate analgesia during and after procedures
  • Providing appropriate recovery conditions
  • Monitoring for complications and intervening promptly
  • Using the lowest effective doses of anesthetic drugs

The American College of Veterinary Internal Medicine (ACVIM) provides resources on equine medicine and anesthesia that support evidence-based practice (ACVIM, www.acvim.org).

Professional Escalation Criteria

Veterinarians should recognize when a case exceeds their expertise or available resources and seek referral or consultation. Escalation criteria include:

  • Horses with severe systemic disease (cardiac, respiratory, renal, hepatic)
  • Procedures requiring specialized equipment or expertise
  • Complications that do not respond to initial management
  • Horses with a history of anesthetic complications
  • Emergency procedures in unstable patients

When escalation is indicated, contact a veterinary anesthesiologist or referral hospital with equine anesthesia capabilities.

Practical Decision Framework for Selecting Anesthetic Protocols in Horses

Selecting the appropriate anesthetic protocol for an equine patient requires a systematic approach that balances patient factors, procedural requirements, and available resources. This section provides a structured decision framework to guide protocol selection, a record system for tracking anesthetic outcomes, and troubleshooting methods for common intra-anesthetic problems. The framework is designed to be used in clinical practice alongside the pre-anesthetic evaluation and monitoring principles discussed in the preceding sections.

Decision Framework for Protocol Selection

The decision framework is organized around three primary axes: patient risk category, procedure type and duration, and available equipment. Each axis generates a score or classification that guides protocol selection.

Patient Risk Classification

Assign each horse to one of three risk categories based on pre-anesthetic evaluation findings.

Low Risk (ASA I-II)

  • Healthy horses with no systemic disease
  • Normal physical examination and laboratory findings
  • No history of anesthetic complications
  • Examples: elective castration, routine dental procedures, minor laceration repair

Moderate Risk (ASA III)

  • Horses with controlled systemic disease
  • Mild to moderate abnormalities on examination or laboratory testing
  • Examples: mild colic with stable vital signs, horses with controlled heaves, geriatric horses with mild age-related changes

High Risk (ASA IV-V)

  • Horses with severe systemic disease that is a constant threat to life
  • Significant abnormalities on examination or laboratory testing
  • Examples: severe colic with cardiovascular compromise, horses with respiratory distress, septic foals, horses with cardiac disease

The Merck Veterinary Manual provides general guidance on anesthetic risk assessment in horses, emphasizing that underlying disease significantly increases the risk of complications (Merck Veterinary Manual, www.merckvetmanual.com).

Procedure Classification

Classify the procedure according to duration and anticipated stimulation level.

Short Procedures (less than 30 minutes)

  • Low stimulation: physical examination, bandage changes, minor wound treatment
  • Moderate stimulation: joint injections, dental floating, minor laceration repair
  • High stimulation: castration, minor surgical procedures

Intermediate Procedures (30 to 90 minutes)

  • Low stimulation: diagnostic imaging under anesthesia
  • Moderate stimulation: arthroscopy, wound reconstruction
  • High stimulation: laparoscopy, fracture repair, sinus surgery

Long Procedures (more than 90 minutes)

  • Low stimulation: prolonged imaging or positioning
  • Moderate stimulation: major orthopedic surgery, abdominal surgery
  • High stimulation: colic surgery, complex fracture repair

Equipment Availability

Assess available equipment for each case.

Full Equipment Available

  • Inhalant anesthetic machine with vaporizer
  • Mechanical ventilator
  • Direct arterial blood pressure monitoring
  • Capnography and pulse oximetry
  • Fluid pump and warming devices

Limited Equipment Available

  • Inhalant anesthetic machine without ventilator
  • Indirect blood pressure monitoring
  • Basic monitoring (pulse oximetry, ECG)
  • Limited fluid warming capability

No Inhalant Equipment Available

  • Only injectable drugs for induction and maintenance
  • Basic monitoring only
  • TIVA protocols required

Protocol Selection Matrix

Use the following matrix to guide protocol selection based on the three axes.

Patient Risk Procedure Duration Equipment Recommended Protocol
Low Short Any Alpha-2 sedation + ketamine/benzodiazepine induction, short TIVA or mask maintenance if needed
Low Intermediate Full Alpha-2 sedation + ketamine/benzodiazepine induction, isoflurane or sevoflurane maintenance
Low Intermediate Limited Alpha-2 sedation + ketamine/benzodiazepine induction, TIVA with romifidine-ketamine-midazolam
Low Long Full Alpha-2 sedation + ketamine/benzodiazepine induction, isoflurane or sevoflurane maintenance with mechanical ventilation
Low Long Limited Alpha-2 sedation + ketamine/benzodiazepine induction, TIVA with romifidine-ketamine-midazolam
Moderate Short Any Alpha-2 sedation + ketamine/benzodiazepine induction, short TIVA or mask maintenance
Moderate Intermediate Full Alpha-2 sedation + ketamine/benzodiazepine induction, isoflurane or sevoflurane maintenance with blood pressure monitoring
Moderate Intermediate Limited Alpha-2 sedation + ketamine/benzodiazepine induction, TIVA with romifidine-ketamine-midazolam
Moderate Long Full Alpha-2 sedation + ketamine/benzodiazepine induction, isoflurane or sevoflurane maintenance with mechanical ventilation and direct blood pressure
Moderate Long Limited Consider referral if possible, TIVA with romifidine-ketamine-midazolam if referral not available
High Any Full Alpha-2 sedation (low dose) + ketamine/benzodiazepine induction, TIVA preferred over inhalant for cardiovascular stability
High Any Limited Stabilize patient, consider referral, TIVA with romifidine-ketamine-midazolam if emergency

A review of total intravenous anesthesia in horses discusses the clinical application of TIVA protocols and their advantages for horses with compromised cardiovascular function (Total intravenous anesthesia in horses, The Veterinary Clinics of North America. Equine Practice, 2013, pubmed.ncbi.nlm.nih.gov/23498048).

Record System for Anesthetic Outcomes

A standardized record system allows tracking of anesthetic outcomes and identification of areas for improvement. The following record template captures essential data for each anesthetic event.

Anesthetic Record Template

Patient Information

  • Horse identification: name, age, breed, weight
  • Date and time of procedure
  • Attending veterinarian and technician

Pre-Anesthetic Data

  • Risk classification (Low/Moderate/High)
  • Physical examination findings
  • Laboratory results (PCV, TP, creatinine, glucose, electrolytes)
  • Fasting duration
  • Hydration status

Drug Administration Record

  • Premedication: drug, dose, route, time
  • Induction: drug, dose, route, time
  • Maintenance: drug, dose/rate, time started, time ended
  • Additional drugs: drug, dose, route, time, indication

Monitoring Record (every 5 to 15 minutes)

  • Time
  • Heart rate
  • Respiratory rate
  • Mean arterial pressure
  • SpO2
  • ETCO2
  • Anesthetic depth assessment
  • Fluid rate and cumulative volume

Complications and Interventions

  • Complication: type, time of onset
  • Intervention: action taken, time
  • Response to intervention

Recovery Data

  • Time from end of maintenance to extubation
  • Time from extubation to first attempt to stand
  • Time to standing
  • Recovery quality score (1=excellent, 2=good, 3=fair, 4=poor, 5=disastrous)
  • Any recovery complications

Outcome Tracking

Maintain a log of all anesthetic events with the following summary data for periodic review.

  • Total number of anesthetics per month/quarter
  • Number of complications by type (hypotension, hypoxemia, cardiac arrest, recovery issues)
  • Complication rate per procedure type
  • Mortality rate
  • Recovery quality scores

Review this data regularly to identify trends and implement quality improvement measures.

Troubleshooting Method for Intra-Anesthetic Problems

When a problem arises during anesthesia, use a systematic troubleshooting approach to identify the cause and implement corrective action.

Hypotension (MAP below 60 mmHg)

Step 1: Confirm the reading

  • Check blood pressure monitor calibration
  • Verify catheter patency and transducer position
  • Obtain a second reading if possible

Step 2: Assess anesthetic depth

  • Is the horse too deep? Reduce vaporizer setting or infusion rate
  • Is the horse too light? Check for movement or response to stimulation

Step 3: Evaluate volume status

  • Check fluid administration rate
  • Assess for blood loss
  • Consider colloid administration if crystalloids are insufficient

Step 4: Consider drug effects

  • Alpha-2 agonists cause vasodilation and bradycardia
  • Inhalant anesthetics cause dose-dependent hypotension
  • Acepromazine can cause prolonged hypotension

Step 5: Implement corrective measures

  • Reduce anesthetic depth if appropriate
  • Increase fluid rate (bolus of 10 to 20 mL/kg crystalloid)
  • Administer inotropic support (dobutamine 1 to 5 mcg/kg/min IV)
  • Consider vasopressors if hypotension persists

The Merck Veterinary Manual provides guidance on managing hypotension during equine anesthesia, emphasizing the importance of maintaining MAP above 60 mmHg (Merck Veterinary Manual, www.merckvetmanual.com).

Hypoxemia (SpO2 below 90% or PaO2 below 60 mmHg)

Step 1: Confirm the reading

  • Check pulse oximeter probe placement and signal quality
  • Obtain arterial blood gas if possible

Step 2: Assess ventilation

  • Is the horse hypoventilating? Check ETCO2
  • Provide assisted or controlled ventilation
  • Increase respiratory rate or tidal volume

Step 3: Evaluate oxygenation

  • Increase inspired oxygen concentration to 100%
  • Check for airway obstruction
  • Reposition the horse to improve ventilation-perfusion matching

Step 4: Consider underlying causes

  • Recumbency causes ventilation-perfusion mismatch in horses
  • Pulmonary disease or edema
  • Bronchospasm

Step 5: Implement corrective measures

  • Provide 100% oxygen
  • Initiate or adjust mechanical ventilation
  • Consider positive end-expiratory pressure (PEEP) of 5 to 10 cmH2O
  • Administer bronchodilators if bronchospasm is suspected

A study comparing respiratory function during TIVA and isoflurane anesthesia in spontaneously breathing ponies found that TIVA may better preserve respiratory function in some cases (Comparison of respiratory function during TIVA (romifidine, ketamine, midazolam) and isoflurane anaesthesia in spontaneously breathing ponies Part I: blood gas analysis and cardiorespiratory variables, Veterinary Anaesthesia and Analgesia, 2014, pubmed.ncbi.nlm.nih.gov/25099938).

Cardiac Arrest

Step 1: Recognize the event

  • Absent pulse, no heart sounds, no ECG activity or ventricular fibrillation
  • Unresponsive to stimulation

Step 2: Initiate CPR immediately

  • Begin chest compressions at 80 to 100 compressions per minute
  • Compress the chest over the heart (left side, behind the elbow)
  • Compress to one-third to one-half of chest width

Step 3: Provide ventilation

  • Ventilate with 100% oxygen
  • Provide one breath every 5 to 6 compressions
  • Ensure endotracheal tube is patent and cuff is inflated

Step 4: Administer drugs

  • Epinephrine 0.01 to 0.02 mg/kg IV every 3 to 5 minutes
  • Atropine 0.01 to 0.02 mg/kg IV for bradycardia or asystole
  • Vasopressin 0.4 to 0.8 U/kg IV as an alternative to epinephrine

Step 5: Defibrillate if indicated

  • Use 2 to 4 J/kg for external defibrillation
  • Repeat every 2 minutes if ventricular fibrillation persists

Step 6: Assess and continue

  • Check for return of spontaneous circulation every 2 minutes
  • Continue CPR until spontaneous circulation returns or resuscitation is deemed futile

The Merck Veterinary Manual notes that successful resuscitation from cardiac arrest in horses is rare but possible with prompt intervention (Merck Veterinary Manual, www.merckvetmanual.com).

Recovery Problems

Step 1: Assess recovery environment

  • Is the recovery stall padded and quiet?
  • Are there obstacles or hazards?
  • Is assistance available if needed?

Step 2: Evaluate the horse's condition

  • Is the horse conscious and responsive?
  • Are there signs of myopathy (stiffness, muscle swelling, reluctance to move)?
  • Are there signs of neuropathy (limb weakness, ataxia)?

Step 3: Manage the recovery

  • Minimize stimulation and noise
  • Allow the horse to recover at its own pace
  • Provide head and tail rope assistance if needed
  • Administer sedation if the horse is excited or thrashing

Step 4: Address complications

  • For myopathy: provide supportive care, anti-inflammatory drugs, and fluid therapy
  • For fractures: stabilize the limb and seek surgical consultation
  • For aspiration: administer antibiotics and respiratory support

Step 5: Document the recovery

  • Record recovery time and quality
  • Note any complications and interventions
  • Follow up with the horse's owner or handler

Common Failure Patterns in Protocol Selection

Recognizing common failure patterns can help prevent complications before they occur.

Failure Pattern 1: Underestimating Patient Risk

Skipping or rushing the pre-anesthetic evaluation leads to undetected comorbidities. Horses with subclinical cardiac disease, respiratory disease, or electrolyte imbalances are at higher risk for complications. Always perform a thorough evaluation and assign a risk classification before selecting a protocol.

Failure Pattern 2: Mismatching Protocol to Procedure Duration

Using a short-acting protocol for a long procedure leads to repeated drug administration and potential accumulation. Using a long-acting protocol for a short procedure leads to prolonged recovery. Match the protocol to the expected procedure duration and have a plan for extending anesthesia if needed.

Failure Pattern 3: Ignoring Equipment Limitations

Attempting inhalant anesthesia without a ventilator for a long procedure in a high-risk horse increases the risk of hypoventilation and hypoxemia. Choose a protocol that matches available equipment and have backup plans for equipment failure.

Failure Pattern 4: Inadequate Monitoring

Failure to monitor vital signs continuously delays recognition of complications. Hypotension and hypoxemia can develop rapidly and require immediate intervention. Use the monitoring record to track trends and identify problems early.

Failure Pattern 5: Poor Recovery Planning

Failing to prepare the recovery environment before the procedure ends leads to rushed recovery management. Prepare the recovery stall, gather assistance, and have sedation and reversal agents available before the horse begins to recover.

Welfare and Safety Context for Protocol Selection

The World Organisation for Animal Health (WOAH) provides standards for animal health and welfare that apply to veterinary procedures, including anesthesia (Animal Health and Welfare, World Organisation for Animal Health, www.woah.org/en/what-we-do/animal-health-and-welfare). These standards emphasize the importance of minimizing stress and pain, ensuring adequate analgesia, and providing appropriate recovery conditions.

When selecting an anesthetic protocol, consider the following welfare implications:

  • Choose drugs and doses that minimize cardiovascular and respiratory depression
  • Provide adequate analgesia for the procedure
  • Use the lowest effective doses to reduce recovery time and complications
  • Monitor vital signs continuously to detect and manage complications
  • Prepare the recovery environment to minimize stress and injury risk

The American College of Veterinary Internal Medicine (ACVIM) provides resources on equine medicine and anesthesia that support evidence-based practice and welfare considerations (ACVIM, www.acvim.org).

Professional Escalation Criteria for Protocol Selection

Recognize when a case exceeds your expertise or available resources and seek referral or consultation. Escalation criteria specific to protocol selection include:

  • High-risk patients (ASA IV-V) that require specialized monitoring and equipment
  • Procedures requiring prolonged anesthesia (more than 2 hours) in moderate or high-risk patients
  • Cases where TIVA is the only option but the veterinarian has limited experience with TIVA protocols
  • Horses with a history of anesthetic complications that require specialized management
  • Emergency procedures in unstable patients that exceed available resources

When escalation is indicated, contact a veterinary anesthesiologist or referral hospital with equine anesthesia capabilities. Document the reason for referral and provide a summary of the patient's condition and any treatments administered.

Frequently Asked Questions

What is the most common complication during equine anesthesia?

Hypotension is the most common cardiovascular complication during equine anesthesia. It results from the combined effects of anesthetic drugs on vascular tone and cardiac function, as well as hypovolemia and excessive anesthetic depth. Maintaining mean arterial pressure above 60 mmHg is critical for organ perfusion.

How do I choose between inhalant anesthesia and TIVA in horses?

The choice depends on the procedure, available equipment, and the horse's condition. Inhalant anesthesia is suitable for most procedures and allows rapid adjustment of anesthetic depth. TIVA may be preferred for horses with compromised cardiovascular function, for procedures where inhalant equipment is unavailable, or to reduce environmental pollution. A study comparing respiratory function during TIVA and isoflurane anesthesia provides evidence that TIVA may offer advantages in some cases (Comparison of respiratory function during TIVA (romifidine, ketamine, midazolam) and isoflurane anaesthesia in spontaneously breathing ponies Part I: blood gas analysis and cardiorespiratory variables, Veterinary Anaesthesia and Analgesia, 2014, pubmed.ncbi.nlm.nih.gov/25099938).

What is the best way to monitor anesthetic depth in horses?

Use multiple parameters including eye position, palpebral reflex, jaw tone, response to surgical stimulation, and vital signs. No single parameter is reliable, and the combination of assessments provides the most accurate evaluation of anesthetic depth.

How do I manage hypotension during equine anesthesia?

Reduce anesthetic depth if possible, increase fluid administration rate, and consider inotropic support. Vasopressors may be used if hypotension persists. The Merck Veterinary Manual provides guidance on managing hypotension during equine anesthesia (Merck Veterinary Manual, www.merckvetmanual.com).

What are the risks of using alpha-2 agonists in horses?

Alpha-2 agonists cause dose-dependent cardiovascular effects including bradycardia, decreased cardiac output, and hypertension followed by hypotension. They also cause respiratory depression and decreased gastrointestinal motility. Use the lowest effective dose and monitor vital signs closely.

How do I prevent hypoxemia during equine anesthesia?

Provide 100% oxygen during anesthesia, maintain adequate ventilation, and monitor oxygenation with pulse oximetry or arterial blood gas analysis. For horses at high risk of hypoxemia, consider TIVA protocols that may better preserve respiratory function compared to inhalant anesthesia.

What should I do if a horse experiences cardiac arrest during anesthesia?

Discontinue anesthetic agents immediately, begin CPR with chest compressions at 80 to 100 compressions per minute, administer epinephrine, provide ventilation with 100% oxygen, and defibrillate if ventricular fibrillation is present. The Merck Veterinary Manual notes that successful resuscitation is rare but possible with prompt intervention (Merck Veterinary Manual, www.merckvetmanual.com).

How do I manage recovery in horses after anesthesia?

Provide a quiet, padded recovery stall and minimize stimulation. Assist recovery with head and tail ropes if needed. Administer sedation as needed to control excitement. Monitor for signs of myopathy, neuropathy, or fractures. The Merck Veterinary Manual emphasizes the importance of careful recovery management (Merck Veterinary Manual, www.merckvetmanual.com).

Related Veterinary Guides

References and Further Reading

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.